Under construction – not a live service
Sign in
Enrolling by invitationEarly phase 1

Pilot Study of BAO-G Technique in TAAA Endovascular Repair

Key facts

Where
Beijing, ChinaSee the site
Phase
Early phase 1

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT06534281, who can take part

Where in China

  • Peking Union Medical College HospitalBeijing, ChinaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Peking Union Medical College Hospital
Trial code
NCT06534281
Record updated
2 August 2024
Original description
Multi-Branch AOrtic Reconstruction With G-iliac System (BAO-G) Technique is a novel technique of endovascular repair of thoracoabdominal aortic aneurysm, which using off-the-shelf iliac branched devices to reconstruct the visceral branches. This study aims to evaluate the safety and efficacy of BAO-G in thoracoabdominal aortic aneurysm endovascular repair.Read full original descriptionShow less

Pilot Study of Multi-Branch AOrtic Reconstruction With G-iliac System (BAO-G) Technique in Thoracoabdominal Aortic Aneurysm Endovascular Repair

Multi-Branch AOrtic Reconstruction With G-iliac System (BAO-G) Technique is a novel technique of endovascular repair of thoracoabdominal aortic aneurysm, which using off-the-shelf iliac branched devices to reconstruct the visceral branches. This study aims to evaluate the safety and efficacy of BAO-G in thoracoabdominal aortic aneurysm endovascular repair.

Inclusion: Patients with TAAA, confirmed by aortic CTA; TAAA diameter ≥ 6cm, or symptomatic TAAA with diameter ≥ 4cm; Informed consent signed.

Exclusion: had a history of previous endovascular or open repair; Uncontrolled autoimmune disease; were pregnant; had other contraindications of endovascular treatment.

ClinicalTrials.gov NCT06534281